Dietary heterocyclic amines as potential human carcinogens: Experimental data from nonhuman primates

In Vivo

Volumn 10, Issue 2, 1996, Pages 145-152

  Thorgeirsson, Unnur P ^a   Snyderwine, Elizabeth G ^a   Gomez, Daniel E ^a   Adamson, Richard H ^a,b,c  

^a NATIONAL CANCER INSTITUTE   (United States)

^b NCI   (United States)

^c American Beverage Association   (United States)

Author keywords

Carcinogenesis; Cardiotoxicity; Cynomolgus monkeys; Heterocyclic amines

Indexed keywords

2 AMINO 1 METHYL 6 PHENYLIMIDAZO[4,5 B]PYRIDINE; 2 AMINO 3 METHYLIMIDAZO[4,5 F]QUINOLINE; CARCINOGEN; HETEROCYCLIC AMINE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CARCINOGENESIS; COOKING; DNA ADDUCT; LIVER CARCINOGENESIS; LIVER MICROSOME; MEAT; METABOLIC ACTIVATION; MONKEY; NONHUMAN; PRIMATE; RAT; RODENT;

EID: 0030068985     PISSN: 0258851X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (38)

1. Sugimura T, Nagao M, Kawachi T, Honda M, Yahagi T, Seino Y, Sato S, Matsukura N, Matsushima T, Shirai A, Sawamura M and Matsumoto H: Mutagen-carcinogens in food, with special reference to highly mutagenic pyrolytic products in broiled foods. In: Origins of human cancer (Hiatt HH, Watson JD and Winsten JA, eds). New York, Cold Spring Harbor, 1977, pp 1561-1577.
2. Felton JS and Knize MG: Heterocyclic-amine mutagens/carcinogens in foods. In: Handbook of experimental pharmacology (Cooper SC and Grover PL, eds). New York, Springer-Verlag, 1990, pp 471-502.
3. Berg I, Overvik E, Nord C-E and Gustafsson J-A: Mutagenic activity in smoke formed during broiling of lean pork at 200, 250 and 300°C. Mutat Res 207: 199-204, 1988.
4. Knize MG, Cunningham PL, Avila JR, Jones AL, Griffin EA Jr. and Felton JS: Formation of mutagenic activity from amino acids heated at cooking temperatures. Food Chem Toxicol. 32: 55-60, 1994.
5. Ohgaki H, Takayama S and Sugimura T: Carcinogenicities of heterocyclic amines in cooked foods. Mutat Res 259: 399-410, 1991.
6. Wakabayashi K: Food-derived mutagens and carcinogens. Cancer Res 52: 2092s-209Ss, 1992.
7. 3-450 of carcinogenic arylamines found in foods. J Natl Cancer Inst 81: 223-227, 1989.
8. Snyderwine EG, Schut HAJ, Adamson RH, Thorgeirsson UP and Thorgeirsson SS: Metabolic activation and genotoxicity of heterocyclic arylamines. Cancer Res 52: 2099s-2102s, 1992.
9. Davis CD, Schut HAJ and Snyderwine EG: Enzymatic phase II activation of the N-hydroxylamines of IQ, MeIQx and PhIP by various organs of monkeys and rats. Carcinogenesis 14: 2091-2096, 1993.
10. Snyderwine EG: Some perspectives on the nutritional aspects of breast cancer research. Food-derived heterocyclic amines as etiologic agents in human mammary cancer. Cancer 74: 1070-1077, 1994.
11. Davis CD, Schut HAJ, Adamson RH, Thorgeirsson UP, Thorgeirsson SS and Snyderwine EG: Mutagenic activation of IQ, PhIP and MeIQx by hepatic microsomes from rat, monkey and man: low mutagenlc activation of MeIQx in cynomolgus monkeys in vitro reflects low DNA adduct levels in vivo. Carcinogenesis 14: 61-65, 1993.
12. Davis CD, Adamson RH and Snyderwine EG: Studies on the mutagenic activation of heterocyclic amines by cynomolgus monkey, rat and human microsomes show that cynomolgus monkeys have a low capacity to N-oxidize the quinoxaline-type heterocyclic amines. Cancer Lett 737: 95-104, 1993.
13. Sadrieh N and Snyderwine EG: Cytochromes P450 in cynomolgus monkeys mutagenically activate 2-amino-3-methylimidazo[4,5-f]quinoline (IQ) but not 2-amino-3,8-dimethylimidazo[4,5-7] quinoxaline (MeIQx). Carcinogenesis 16, 1549-1555, 1995.
14. McKinnon RA and McManus ME: Function and localization of cytochrome P450 involved in the metabolic activation of food-derived heterocyclic amines. In: Heterocyclic amines in cooked foods: possible human carcinogens (Adamson RH, Gustafsson J-A, Nobuyuki I, Nagao M, Sugimura T, Wakabayashi K and Yamazoe Y, eds). New Jersey, Princeton Scientific Publishing Co, 1995, pp 145-153.
15. Snyderwine EG, Buonarati MH, Felton JS and Turteltaub KW: Metabolism of the food-derived mutagen/carcinogen 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) in nonhuman primates. Carcinogenesis 14: 2517-2522, 1993.
16. Snyderwine EG, Welti DH, Davis CD, Fay LB and Turesky RJ: Metabolism of the food-derived carcinogen 2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline (MeIQx) in nonhuman primates. Carcino-genesis 16: 1377-1384, 1995.
17. 32P-postlabeling analysis of IQ, MeIQx and PhIP adducts formed in vitro in DNA and polynucleotides and found in vivo in hepatic DNA from IQ-, MeIQx- and PhIP-treated monkeys. Carcinogenesis 14: 1389-1395, 1993.
18. Snyderwine EG, Schut HAJ, Sugimura T, Nagao M and Adamson RH: DNA adduct levels of 2-amino-1-methyl-6-phenylimidazo[4,5-b] pyridine (PhIP) in tissues of cynomolgus monkeys after single or multiple dosing. Carcinogenesis 15: 2757-2761, 1994.
19. Snyderwine EG, Welti DH, Fay LB, Würzner HP and Turesky RJ: Metabolism of the food mutagen 2-amino-3-methylimidazo[4,5-f]quinoline in nonhuman primates undergoing carcinogen bioassay. Chem Res Toxicol 5: 843-851, 1992.
20. Stillwell WO, Turesky RJ, Gross GA, Skipper PL and Tannenbaum SR: Human urinary excretion of sulfamate and glucuronide conjugates of 2-amino-3,8-dimethylimidazo[4,5-f] quinoxaline (MeIQx). Cancer Epidemiol Biomarkers Preven 3: 399-405, 1994.
21. Turesky RJ, Stillwell WGS, Skipper PL and Tannenbaum SR: Metabolism of the food-borne carcinogens 2-amino-3-methylimidazo[4,5-f] quinolineand 2-amino-3,8-dimethylimidazo[4,5-f] quinoxaline in the rat as a model for human biomonitoring. Environ Health Perspect 99: 123-128, 1993.
22. Lynch AM, Knize MG, Boobis AR, Gooderham NJ, Davies DS and Murray S: Intra-and inter-individual variability in systemic exposure in humans to 2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline and 2-amino-1-methyl-6-phenylimidazo[4,5,b]pyridine, carcinogens present in cooked beef. Cancer Res 52: 6216-6223, 1992.
23. Ushiyama H, Wakabayashi K, Hirose M, Itoh H, Sugimura T and Nagao M: Presence of carcinogenic heterocyclic amines in urine of healthy volunteers eating normal diet, but not of inpatients receiving parenteral alimentation. Carcinogenesis 12: 1417-1422, 1991.
24. Murray S, Gooderham NJ, Boobis AR and Davies DS: Detection and measurement of MeIQx in human urine after ingestion of a cooked meat meal. Carcinogenesis 10: 763-765, 1984.
25. Hayatsu H, Hayatsu T and Ohara Y: Mutagenicity of human urine caused by ingestion of fried ground beef. Jpn J Cancer Res 76: 445-448, 1985.
26. Hayatsu H, Hayatsu T and Wataya Y: Use of blue cotton for detection of mutagenicity in human feces excreted after ingestion of cooked meat. Environ Health Perspect 67: 31-34, 1986.
27. Adamson RH, Thorgeirsson UP, Snyderwine EG, Thorgeirsson SS, Reeves J, Dalgard DW, Takayama S and Sugimura T: Carcinogenicity of 2-amino-3-methylimidazo[4,5-f]quinoline in nonhuman primates: Induction of tumor in three macaques. Jpn J Cancer Res 81: 10-14, 1990.
28. Thorgeirsson UP, Dalgard DW, Reeves J and Adamson RH: Tumor incidence in a chemical carcinogenesis study of nonhuman primates. Reg Toxicol and Pharmacol 19: 130-151, 1994.
29. Ruebner BH, Michas C, Kanayama R and Bannasch P: Sequential hepatic histologic and histochemical changes produced by dimethylnitrosamine in the rhesus monkey. J Natl Cancer Inst 57: 1261-1267, 1976.
30. Cortinovis C, Klimek F and Nogueira E: Rat hepatocarcinogenesis induced by N-nitrosodiethylamine and N-nitrosomorpholine continously administered at low doses. Am J Pathol 139: 1157-1171, 1991.
31. Karhunen PJ and Penttila A: Preneoplastic lesions of human liver. Hepatogastroenterol 34: 10-15, 1987.
32. Bannasch P, Enzmann H, Hacker HJ, Weber E and Zerban H: Comparative pathobiology of hepatic preneoplasia. In: Liver cell carcinoma (Bannasch P, Keppler D and Weber G, eds). Dordrecht, Boston, London, Kluwer Academic Publishers, 1989, pp 53-73.
33. Van Eyken P, Sciot R, Paterson A, Callea F, Kew MC and Desmet VJ: Cytokeratin expression in hepatocellular carcinoma. Human Pathol 19: 562-568, 1988.
34. Derick H, Lau DHW, Duran GE and Sikic BI: Characterization of covalent DNA binding of morpholino and cyanomorpholino derivatives of doxorubicin. J Natl Cancer Inst 84: 1587-1592, 1992.
35. Ferrans VJ, Sanchez JA and Herman EH: Pathologic anatomy of animal models of the cardiotoxicity of anthracyclines. In. Cancer treatment and the heart (Muggia FM, Green MD and Speyer JL, eds). Baltimore, Johns Hopkins University Press, 1991, pp 89-113.
36. Davis CD, Farb A, Thorgeirsson SS, Virmani R and Snyderwine EG: Cardiotoxicity of heterocyclic amine food mutagens in cultured myocytes and in rats. Toxicol Appl Pharmacol 124: 201-211, 1994.
37. Davis CD and Snyderwine EG: Protective effect of N-acetylcysteine against heterocyclic amine-induced cardiotoxicity in cultured myocytes and in rats. Fd Chem Toxicol 33: 641-651, 1995.
38. Layton DW, Bogen KT, Knize MG, Hatch FT, Johnson VM and Felton JS: Cancer risk of heterocyclic amines in cooked foods: an analysis and implications for research. Carcinogenesis 16: 39-52, 1995.